UK markets closed
  • FTSE 100

    -20.35 (-0.30%)
  • FTSE 250

    -196.81 (-0.95%)
  • AIM

    -2.78 (-0.23%)

    -0.0042 (-0.37%)

    -0.0046 (-0.34%)

    +59.45 (+0.26%)
  • CMC Crypto 200

    +41.45 (+6.79%)
  • S&P 500

    -11.60 (-0.30%)
  • DOW

    -179.03 (-0.57%)

    -1.15 (-2.16%)

    -10.40 (-0.56%)
  • NIKKEI 225

    -125.41 (-0.44%)

    -479.91 (-1.60%)
  • DAX

    -32.70 (-0.24%)
  • CAC 40

    -31.22 (-0.56%)

Worldwide Next-generation Sequencing (NGS) Industry to 2025 - Players Include 10x Genomics, BGI Group and Eurofins Scientific

Research and Markets
·10-min read

Dublin, Dec. 17, 2020 (GLOBE NEWSWIRE) -- The "Next-generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to's offering.

The global next-generation sequencing (NGS) market is currently witnessing robust growth. Next-generation sequencing, or high-throughput sequencing, refers to the process of determining the sequence of nucleotides in a section of the DNA. It includes procedures such as sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing and single-molecule real-time (SMRT) sequencing. It is a cost-effective solution that offers precise results with high accuracy and speed. This enables the analysis of millions of DNA molecules simultaneously, which facilitates research in the fields of personalized and genetic medicines, agriculture and animal research, and clinical diagnostics.

The increasing prevalence of chronic medical ailments, such as cancer, along with various technological advancements in the field of medical sciences, is one of the key factors driving the growth of the market. Owing to the widespread adoption of liquid biopsies in cancer diagnostics, there has been a significant increase in the utilization of NGS technologies. These technologies utilize cell-free circulating tumor DNA (ctDNA) as a non-invasive cancer biomarker for real-time cancer monitoring and detection. Furthermore, the increasing adoption of genome mapping programs to predict the development of various diseases is also providing a boost to the market growth. Genetic maps are used for guiding scientists to analyze the genes that are responsible for increasing the prevalence of diabetes, heart diseases, asthma, cancer and psychiatric conditions.
Additionally, various technological advancements and integration with the cloud-computing systems for improved data management, are creating a positive impact on the market growth. Other factors, including the declining costs of NGS systems and extensive research and development (R&D) activities in the field of sequencing chemistry, molecular biology and technical engineering, are projected to drive the market further. Looking forward, the publisher expects the market to register a CAGR of around 17% during 2020-2025.

Breakup by Sequencing Type:

  • Whole Genome Sequencing

  • Targeted Resequencing

  • Whole Exome Sequencing

  • RNA Sequencing

  • CHIP Sequencing

  • De Novo Sequencing

  • Methyl Sequencing

  • Others

Breakup by Product Type:

  • Instruments

  • Reagents and Consumables

  • Software and Services

Breakup by Technology:

  • Sequencing by Synthesis

  • Ion Semiconductor Sequencing

  • Single-Molecule Real-Time Sequencing

  • Nanopore Sequencing

  • Others

Breakup by Application:

  • Drug Discovery and Personalized Medicine

  • Genetic Screening

  • Diagnostics

  • Agriculture and Animal Research

  • Others

Breakup by End-User:

  • Academic Institutes & Research Centers

  • Hospitals & Clinics

  • Pharmaceutical & Biotechnology Companies

  • Others

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc., etc.

Key Questions Answered in this Report:

  • How has the global next-generation sequencing market performed so far and how will it perform in the coming years?

  • What are the key regional markets?

  • What is the breakup of the market based on the sequencing type?

  • What is the breakup of the market based on the product type?

  • What is the breakup of the market based on the technology?

  • What is the breakup of the market based on the application?

  • What is the breakup of the market based on the end-user?

  • What are the various stages in the value chain of the industry?

  • What are the key driving factors and challenges in the industry?

  • What is the structure of the global next-generation sequencing market and who are the key players?

  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Next-Generation Sequencing Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Forecast

6 Market Breakup by Sequencing Type
6.1 Whole Genome Sequencing
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Targeted Resequencing
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Whole Exome Sequencing
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 RNA Sequencing
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 CHIP Sequencing
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 De Novo Sequencing
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Methyl Sequencing
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast

7 Market Breakup by Product Type
7.1 Instruments
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Reagents and Consumables
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Software and Services
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Technology
8.1 Sequencing by Synthesis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ion Semiconductor Sequencing
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Single-Molecule Real-Time Sequencing
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Nanopore Sequencing
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by Application
9.1 Drug Discovery and Personalized Medicine
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Genetic Screening
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Diagnostics
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Agriculture and Animal Research
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast

10 Market Breakup by End-User
10.1 Academic Institutes & Research Centers
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Hospitals & Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Pharmaceutical & Biotechnology Companies
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast

11 Market Breakup by Region
11.1 North America
11.1.1 United States Market Trends Market Forecast
11.1.2 Canada Market Trends Market Forecast
11.2 Asia Pacific
11.2.1 China Market Trends Market Forecast
11.2.2 Japan Market Trends Market Forecast
11.2.3 India Market Trends Market Forecast
11.2.4 South Korea Market Trends Market Forecast
11.2.5 Australia Market Trends Market Forecast
11.2.6 Indonesia Market Trends Market Forecast
11.2.7 Others Market Trends Market Forecast
11.3 Europe
11.3.1 Germany Market Trends Market Forecast
11.3.2 France Market Trends Market Forecast
11.3.3 United Kingdom Market Trends Market Forecast
11.3.4 Italy Market Trends Market Forecast
11.3.5 Spain Market Trends Market Forecast
11.3.6 Russia Market Trends Market Forecast
11.3.7 Others Market Trends Market Forecast
11.4 Latin America
11.4.1 Brazil Market Trends Market Forecast
11.4.2 Mexico Market Trends Market Forecast
11.4.3 Others Market Trends Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast

12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Agilent Technologies Inc. Company Overview Product Portfolio Financials SWOT Analysis
16.3.2 Becton Dickinson and Company Company Overview Product Portfolio Financials SWOT Analysis
16.3.3 10x Genomics Company Overview Product Portfolio
16.3.4 BGI Group Company Overview Product Portfolio
16.3.5 Eurofins Scientific Company Overview Product Portfolio
16.3.6 F. Hoffmann-La Roche AG Company Overview Product Portfolio Financials
16.3.7 Illumina Inc. Company Overview Product Portfolio Financials SWOT Analysis
16.3.8 Genewiz Company Overview Product Portfolio
16.3.9 Macrogen Inc. Company Overview Product Portfolio Financials
16.3.10 Oxford Nanopore Technologies Company Overview Product Portfolio Financials SWOT Analysis
16.3.11 Pacific Biosciences Company Overview Product Portfolio Financials
16.3.12 Perkinelmer Inc. Company Overview Product Portfolio Financials SWOT Analysis
16.3.13 Thermo Fisher Scientific Inc. Company Overview Product Portfolio Financials SWOT Analysis
16.3.14 Qiagen N.V. Company Overview Product Portfolio Financials SWOT Analysis
16.3.15 Genapsys Inc. Company Overview Product Portfolio

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900